Chronic AT(1) receptor blockade alters autonomic balance and sympathetic responses in hypertension

S M Bezerra1, C M dos Santos, E D Moreira

  • 1Department of Physiology and Biophysics, ICB, University of São Paulo, São Paulo, SP, Brazil.

Insights

Losartan treatment, by blocking angiotensin II, helps normalize heart rate control and sympathetic nerve activity in a coarctation hypertension model. This suggests angiotensin II influences sympathovagal balance during hypertension development.

Area of Science:

  • Cardiovascular Physiology
  • Hypertension Research
  • Autonomic Nervous System Regulation

Background:

  • Coarctation-induced hypertension impairs autonomic reflex control.
  • Angiotensin II plays a role in hypertension and autonomic dysfunction.

Purpose of the Study:

  • To investigate the role of angiotensin II blockade in modulating efferent autonomic pathways during coarctation hypertension.
  • To analyze the impact of losartan on sympathetic nerve activity and baroreceptor function in this model.

Main Methods:

  • Induction of hypertension via subdiaphragmatic aortic coarctation in rats.
  • Chronic administration of losartan (angiotensin II receptor blocker) or vehicle.
  • Assessment of heart rate variability using power spectral analysis.
  • Recording of sympathetic splanchnic nerve activity and blood pressure in anesthetized rats.

Main Results:

  • Losartan reduced basal blood pressure but did not prevent hypertension development.
  • Hypertension in vehicle-treated rats altered heart rate power spectral density towards low-frequency components.
  • Angiotensin II blockade prevented changes in sympathetic activity/pressure relationship and power spectral density during hypertension.
  • Increased sympathetic outflow during baroreceptor unloading was observed in hypertensive rats without AT(1) blockade.

Conclusions:

  • Angiotensin II, via AT(1) receptors, contributes to altered sympathovagal balance in coarctation hypertension.
  • This action facilitates sympathetic outflow to the heart and circulation during baroreceptor unloading.
  • The effects of angiotensin II are independent of pre-existing pressure levels.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...